Abstract
INTRODUCTION
This report details the Market for Blood Disorder Treatments. The market is
rapidly growing due to recent advancements in pharmaceutical products,
advancements in drug delivery of medications and accurate diagnosis. Emphasis
has been placed on early detection and treatment of disorders. There are
issues surrounding this market that are currently in the news that will
ultimately shape this market for the future. An assessment of this market is
presented to ensure that participants in the market do not get caught off
guard, not having time to prepare for the future developments.
The objectives of the study are to heighten the awareness of blood disorders,
their consequences and their treatments. The study analyzes pharmaceutical
entities that are currently on the market and new products that are on the
horizon.
SCOPE OF STUDY
This report contains:
- Descriptions of various types of blood disorder treatments for anemia,
hemophilia, neutropenia and thrombosis
- The current market status of blood disorder treatments, trends and
forecasts for growth over the next 5 years
- Discussion of new technologies with a thorough patent analysis
- Analysis of the major overhaul of the U.S. Food and Drug Administration' s
approval process for blood disorder treatments
- Profiles of major players in the blood disorder treatment market.
METHODOLOGY AND INFORMATION SOURCES
The information and analysis presented in this BCC Research report are based
on extensive first-hand interviews with primary executives, product managers,
and clinical specialists in the area of blood disorders. Background
information was obtained from various government, business, medical, and
hematology journals and trade magazines, as well as interviews with
hematologists, physicians, and nurses involved in hematological conditions.
Key information from published literature was used to conduct interviews with
industry participants to validate and obtain expert opinions on current and
future trends in the area of blood disorders. Interviews were also conducted
to confirm and/or adjust market size and market share estimates, as well as to
formulate market projections.
All market data pertain to revenues at the manufacturer' s level. Data are
expressed in current U.S. dollars. The base year was 2007. Historical data are
provided for 2005 and 2006, and forecast data are provided for 2012.
Historical, base year, and forecast data are provided for each market segment
and subsegment. Market shares are provided for each market segment for the
2007 base year.
| 
View Cart
